Biobizkaia
Research center
University of Tasmania
Hobart, AustraliaPublications in collaboration with researchers from University of Tasmania (11)
2021
2019
-
Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension study
Arthritis Research and Therapy, Vol. 21, Núm. 1
2017
-
Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial
Arthritis and Rheumatology, Vol. 69, Núm. 9, pp. 1903-1913
-
Response to interferon-beta treatment in multiple sclerosis patients: A genome-wide association study
Pharmacogenomics Journal, Vol. 17, Núm. 4, pp. 312-318
2016
2013
-
Lessons from the Hvidoere International Study Group on childhood diabetes: Be dogmatic about outcome and flexible in approach
Pediatric Diabetes, Vol. 14, Núm. 7, pp. 473-480
2012
-
Closing the case of APOE in multiple sclerosis: No association with disease risk in over 29 000 subjects
Journal of Medical Genetics, Vol. 49, Núm. 9, pp. 558-562
-
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
The Lancet, Vol. 380, Núm. 9859, pp. 2197-2223
-
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
The Lancet, Vol. 380, Núm. 9859, pp. 2163-2196